Physician profile
Robert Tayengco
NPI 1215038401
$1,415.23
in general payments reported to CMS, 2019-2025
17 companies · $63.16 in 2025
The $63.16 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.51 · 2020: $31.25 · 2021: $202 · 2022: $595 · 2023: $324 · 2024: $131 · 2025: $63.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $517.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $748.38 | 2021-2024 | Ubrelvy, Qulipta, Linzess |
| Astellas Pharma US INC | $160.20 | 2023-2024 | Veozah, Myrbetriq |
| Abbott Laboratories | $128.70 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $111.11 | 2021-2023 | |
| Glaxosmithkline, LLC. | $37.96 | 2019-2024 | Shingrix, Arexvy |
| Pfizer INC. | $26.66 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.43 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $25.37 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $20.96 | 2019 | |
| Merck Sharp & Dohme LLC | $19.21 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $18.79 | 2025 | Rexulti |
| Dexcom, INC. | $16.78 | 2023 | Dexcom G6 Transmitter |
| Amarin Pharma, INC. | $16.70 | 2020 | |
| Amgen INC. | $15.27 | 2025 | Repatha, Otezla |
| E.R. Squibb & Sons, L.L.C. | $14.98 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $14.55 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $14.18 | 2025 | Dupixent |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Tayengco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.